BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 24176397)

  • 1. Antiproliferative activities and SAR studies of substituted anthraquinones and 1,4-naphthoquinones.
    Bhasin D; Etter JP; Chettiar SN; Mok M; Li PK
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6864-7. PubMed ID: 24176397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-molecule STAT3 signaling pathway modulators from Polygonum cuspidatum.
    Liu J; Zhang Q; Chen K; Liu J; Kuang S; Chen W; Yu Q
    Planta Med; 2012 Sep; 78(14):1568-70. PubMed ID: 22855270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and studies of small molecule STAT3 inhibitors.
    Bhasin D; Cisek K; Pandharkar T; Regan N; Li C; Pandit B; Lin J; Li PK
    Bioorg Med Chem Lett; 2008 Jan; 18(1):391-5. PubMed ID: 18006313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer activity and SAR studies of substituted 1,4-naphthoquinones.
    Bhasin D; Chettiar SN; Etter JP; Mok M; Li PK
    Bioorg Med Chem; 2013 Aug; 21(15):4662-9. PubMed ID: 23791367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.
    Lin L; Hutzen B; Li PK; Ball S; Zuo M; DeAngelis S; Foust E; Sobo M; Friedman L; Bhasin D; Cen L; Li C; Lin J
    Neoplasia; 2010 Jan; 12(1):39-50. PubMed ID: 20072652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two small molecule compounds, LLL12 and FLLL32, exhibit potent inhibitory activity on STAT3 in human rhabdomyosarcoma cells.
    Wei CC; Ball S; Lin L; Liu A; Fuchs JR; Li PK; Li C; Lin J
    Int J Oncol; 2011 Jan; 38(1):279-85. PubMed ID: 21109950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationship studies of naphthoquinones as STAT3 inhibitors.
    Yamashita M; Nakamori Y; Tsukamoto A; Furuno N; Iida A
    Bioorg Med Chem; 2023 Jul; 90():117331. PubMed ID: 37343498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Napabucasin and Related Heterocycle-Fused Naphthoquinones as STAT3 Inhibitors with Antiproliferative Activity against Cancer Cells.
    Löcken H; Clamor C; Müller K
    J Nat Prod; 2018 Jul; 81(7):1636-1644. PubMed ID: 30003778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 inhibitory activity of naphthoquinones isolated from Tabebuia avellanedae.
    Tahara T; Watanabe A; Yutani M; Yamano Y; Sagara M; Nagai S; Saito K; Yamashita M; Ihara M; Iida A
    Bioorg Med Chem; 2020 Mar; 28(6):115347. PubMed ID: 32044231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization and antiproliferative activity of 1,2-naphthoquinone and its derivatives.
    Shukla S; Srivastava RS; Shrivastava SK; Sodhi A; Kumar P
    Appl Biochem Biotechnol; 2012 Jul; 167(5):1430-45. PubMed ID: 22258648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of New Shikonin Derivatives as Antitumor Agents Targeting STAT3 SH2 Domain.
    Qiu HY; Zhu X; Luo YL; Lin HY; Tang CY; Qi JL; Pang YJ; Yang RW; Lu GH; Wang XM; Yang YH
    Sci Rep; 2017 Jun; 7(1):2863. PubMed ID: 28588262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of novel plumbagin derivatives as potent antitumor agents with STAT3 inhibition.
    Li N; Ou J; Bao N; Chen C; Shi Z; Chen L; Sun J
    Bioorg Chem; 2020 Nov; 104():104208. PubMed ID: 32919131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annulation of substituted anthracene-9,10-diones yields promising selectively antiproliferative compounds.
    Castro-Castillo V; Suárez-Rozas C; Castro-Loiza N; Theoduloz C; Cassels BK
    Eur J Med Chem; 2013 Apr; 62():688-92. PubMed ID: 23454511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antiproliferative activity of 1,4-bis(dimethylamino)-9,10-anthraquinone derivatives against P388 mouse leukemic tumor cells.
    Jin GZ; Jin HS; Jin LL
    Arch Pharm Res; 2011 Jul; 34(7):1071-6. PubMed ID: 21811913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel series of napabucasin derivatives as orally active inhibitors of signal transducer and activator of transcription 3 (STAT3).
    Li C; Chen C; An Q; Yang T; Sang Z; Yang Y; Ju Y; Tong A; Luo Y
    Eur J Med Chem; 2019 Jan; 162():543-554. PubMed ID: 30472602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The small molecule, LLL12, inhibits STAT3 phosphorylation and induces apoptosis in medulloblastoma and glioblastoma cells.
    Ball S; Li C; Li PK; Lin J
    PLoS One; 2011 Apr; 6(4):e18820. PubMed ID: 21526200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines.
    Couto JI; Bear MD; Lin J; Pennel M; Kulp SK; Kisseberth WC; London CA
    BMC Vet Res; 2012 Dec; 8():244. PubMed ID: 23244668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthraquinone and naphthoquinone derivatives from the roots of Coptosapelta flavescens.
    Kongyen W; Rukachaisirikul V; Phongpaichit S; Sawangjaroen N; Songsing P; Madardam H
    Nat Prod Commun; 2014 Feb; 9(2):219-20. PubMed ID: 24689295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of naphthoquinone derivatives as antiproliferative agents and 20S proteasome inhibitors.
    Xu K; Xiao Z; Tang YB; Huang L; Chen CH; Ohkoshi E; Lee KH
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2772-4. PubMed ID: 22437113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anticancer structure activity relationship investigation of cationic anthraquinone analogs.
    Shrestha JP; Fosso MY; Bearss J; Chang CW
    Eur J Med Chem; 2014 Apr; 77():96-102. PubMed ID: 24631728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.